Investment Firm
Overview
Sequenom provides genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders.
May 21, 2010
Post Ipo Equity
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Sequenom raised $51605250 on 2010-05-21 in Post-IPO Equity
Sequenom provides genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders.
Company Funding History
4
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Nov 08, 2001 | Grant - Sequenom | 1 | - | 2.2M |
Dec 29, 2009 | Post-IPO Equity - Sequenom | - | 1.5M | |
May 21, 2010 | Post-IPO Equity - Sequenom | - | 51.6M | |
Sep 24, 2012 | Post-IPO Debt - Sequenom | - | 130.0M |
Recent Activity
There is no recent news or activity for this profile.